Emergent BioSolutions Inc. (EBS)
NYSE · Healthcare
Emergent BioSolutions Inc. EBITDA 2009–2025
Emergent BioSolutions Inc. annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Emergent BioSolutions Inc. ebitda for the quarter ending March 31, 2026 was 34.0 M, a 54.85% decrease year-over-year.
- Emergent BioSolutions Inc. ebitda for the twelve months ending March 31, 2026 was 64.0 M, a 64.02% decrease year-over-year.
- Emergent BioSolutions Inc. annual ebitda for 2025 was 195.9 M, a 195800.00% increase from 2024.
- Emergent BioSolutions Inc. annual ebitda for 2024 was 100000, a 100.02% decrease from 2023.
- Emergent BioSolutions Inc. annual ebitda for 2023 was -601.3 M, a 2152.06% increase from 2022.
- Emergent BioSolutions Inc. annual ebitda for 2022 was -26.7 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Emergent BioSolutions Inc. EBITDA — FAQ
Emergent BioSolutions Inc. (EBS) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EBS's ebitda history?
The chart and table above show Emergent BioSolutions Inc.'s ebitda by year and by quarter, including the growth rate.